Medication Description: Conference (Conferon)
CONFERON (Conferon) *.
Capsules containing 250 mg of iron (II) sulfate (correspond to 50 mg of elemental iron) and 35 mg of dioctyl sodium sulfosuccinate. The latter is a surfactant that promotes the absorption of iron and, thus, its therapeutic efficacy.
Applied, like other iron preparations, with iron deficiency anemia of various etiologies.
The average dose for adults and adolescents - 1 to 2 capsules 3 times a day; for children aged 3–6 years, 1 capsule 2 times a day, 7–12 years 1 capsule 3 times a day.
Capsules are swallowed without chewing, after meals.
Form release: in a package of 50 capsules.
Produced in Hungary.